Skip to main content
Top
Published in: European Journal of Epidemiology 5/2013

Open Access 01-05-2013 | RISK FACTORS

Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies

Authors: David A. Leon, Vladimir M. Shkolnikov, Svetlana Borinskaya, Juan-Pablo Casas, Alun Evans, Artyom Gil, Frank Kee, Nikolay Kiryanov, Martin McKee, Mark G. O’Doherty, George B. Ploubidis, Olga Polikina, Maxim Vassiliev, Stefan Blankenberg, Hugh Watkins

Published in: European Journal of Epidemiology | Issue 5/2013

Login to get access

Abstract

Russia has very high mortality from cardiovascular disease (CVD), with evidence that heavy drinking may play a role. To throw further light on this association we have studied the association of alcohol with predictors of CVD risk including B-type natriuretic peptide (BNP). Levels of BNP increase primarily in response to abnormal cardiac chamber wall stretch which can occur both as a result of atherosclerosis as well as due to other types of damage to the myocardium. No previous population-based studies have investigated the association with alcohol. We analysed cross-sectional data on drinking behaviour in 993 men aged 25–60 years from the Izhevsk Family Study 2 (IFS2), conducted in the Russian city of Izhevsk in 2008–2009. Relative to non-drinkers, men who drank hazardously had an odds ratio (OR) of being in the top 20 % of the BNP distribution of 4.66 (95 % CI 2.13, 10.19) adjusted for age, obesity, waist–hip ratio, and smoking. Further adjustment for class of hypertension resulted in only slight attenuation of the effect, suggesting that this effect was not secondary to the influence of alcohol on blood pressure. In contrast hazardous drinking was associated with markedly raised ApoA1 and HDL cholesterol levels, but had little impact on levels of ApoB and LDL cholesterol. Similar but less pronounced associations were found in the Belfast (UK) component of the PRIME study conducted in 1991. These findings suggest that the association of heavy drinking with increased risk of cardiovascular disease may be partly due to alcohol-induced non-atherosclerotic damage to the myocardium.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–8.PubMedCrossRef Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–8.PubMedCrossRef
2.
go back to reference Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–63.PubMedCrossRef Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–63.PubMedCrossRef
3.
go back to reference Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120:2177–87.PubMedCrossRef Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120:2177–87.PubMedCrossRef
4.
go back to reference Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J. 2007;28:1678–82.PubMedCrossRef Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J. 2007;28:1678–82.PubMedCrossRef
5.
go back to reference McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 2001;86:21–6.PubMedCrossRef McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 2001;86:21–6.PubMedCrossRef
6.
go back to reference Otsuka T, Kawada T, Seino Y, Ibuki C, Katsumata M, Kodani E. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease. Am J Cardiol. 2010;106:1456–60.PubMedCrossRef Otsuka T, Kawada T, Seino Y, Ibuki C, Katsumata M, Kodani E. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease. Am J Cardiol. 2010;106:1456–60.PubMedCrossRef
7.
go back to reference Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600.PubMedCrossRef Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600.PubMedCrossRef
8.
go back to reference Pfister R, Sharp S, Luben R, Welsh P, Barroso I, Salomaa V, et al. Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med. 2011;8:e1001112.PubMedCrossRef Pfister R, Sharp S, Luben R, Welsh P, Barroso I, Salomaa V, et al. Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med. 2011;8:e1001112.PubMedCrossRef
9.
go back to reference Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, et al. N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol. 2011;58:56–64.PubMedCrossRef Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, et al. N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol. 2011;58:56–64.PubMedCrossRef
10.
go back to reference Radvan M, Svoboda P, Radvanova J, Stumar J, Scheer P. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients. Hepatogastroenterology. 2009;56:181–5.PubMed Radvan M, Svoboda P, Radvanova J, Stumar J, Scheer P. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients. Hepatogastroenterology. 2009;56:181–5.PubMed
11.
go back to reference Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol. 2005;20:1115–20.PubMedCrossRef Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol. 2005;20:1115–20.PubMedCrossRef
12.
go back to reference Hofer P, Syeda B, Bergler-Klein J, Friedrich F, Lesch OM, Vyssoki B, et al. Amino-terminal pro-B-type brain natriuretic peptide: screening for cardiovascular disease in the setting of alcoholism. Alcohol Alcohol. 2011;46:247–52.PubMedCrossRef Hofer P, Syeda B, Bergler-Klein J, Friedrich F, Lesch OM, Vyssoki B, et al. Amino-terminal pro-B-type brain natriuretic peptide: screening for cardiovascular disease in the setting of alcoholism. Alcohol Alcohol. 2011;46:247–52.PubMedCrossRef
13.
go back to reference Ljubicic N, Gomercic M, Zekanovic D, Bodrozic-Dzakic T, Djuzel A. New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices. Croat Med J. 2012;53:374–8.PubMedCrossRef Ljubicic N, Gomercic M, Zekanovic D, Bodrozic-Dzakic T, Djuzel A. New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices. Croat Med J. 2012;53:374–8.PubMedCrossRef
14.
go back to reference Roerecke M, Greenfield TK, Kerr WC, Bondy S, Cohen J, Rehm J. Heavy drinking occasions in relation to ischaemic heart disease mortality–an 11–22 year follow-up of the 1984 and 1995 US national alcohol surveys. Int J Epidemiol. 2011;40:1401–10.PubMedCrossRef Roerecke M, Greenfield TK, Kerr WC, Bondy S, Cohen J, Rehm J. Heavy drinking occasions in relation to ischaemic heart disease mortality–an 11–22 year follow-up of the 1984 and 1995 US national alcohol surveys. Int J Epidemiol. 2011;40:1401–10.PubMedCrossRef
16.
go back to reference Sull JW, Yi SW, Nam CM, Choi K, Ohrr H. Binge drinking and hypertension on cardiovascular disease mortality in Korean men and women: a Kangwha cohort study. Stroke. 2010;41:2157–62.PubMedCrossRef Sull JW, Yi SW, Nam CM, Choi K, Ohrr H. Binge drinking and hypertension on cardiovascular disease mortality in Korean men and women: a Kangwha cohort study. Stroke. 2010;41:2157–62.PubMedCrossRef
17.
go back to reference Shestov DB, Deev AD, Klimov AN, Davis CE, Tyroler HA. Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian lipid research clinics prevalence follow-up study. Circulation. 1993;88:846–53.PubMedCrossRef Shestov DB, Deev AD, Klimov AN, Davis CE, Tyroler HA. Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian lipid research clinics prevalence follow-up study. Circulation. 1993;88:846–53.PubMedCrossRef
18.
go back to reference Averina M, Nilssen O, Brenn T, Brox J, Kalinin AG, Arkhipovsky VL. High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study 2000. Eur J Epidemiol. 2003;18:871–8.PubMedCrossRef Averina M, Nilssen O, Brenn T, Brox J, Kalinin AG, Arkhipovsky VL. High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study 2000. Eur J Epidemiol. 2003;18:871–8.PubMedCrossRef
19.
go back to reference Roberts B, Stickley A, Balabanova D, Haerpfer C, McKee M. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66:1079–82. Roberts B, Stickley A, Balabanova D, Haerpfer C, McKee M. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66:1079–82.
20.
go back to reference Pomerleau J, Gilmore A, McKee M, Rose R, Haerpfer CW. Determinants of smoking in eight countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Addiction. 2004;99:1577–85.PubMedCrossRef Pomerleau J, Gilmore A, McKee M, Rose R, Haerpfer CW. Determinants of smoking in eight countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Addiction. 2004;99:1577–85.PubMedCrossRef
21.
go back to reference Leon DA, Chenet L, Shkolnikov VM, Zakharov S, Shapiro J, Rakhmanova G, et al. Huge variation in Russian mortality rates 1984–1994: artefact, alcohol, or what? Lancet. 1997;350:383–8.PubMedCrossRef Leon DA, Chenet L, Shkolnikov VM, Zakharov S, Shapiro J, Rakhmanova G, et al. Huge variation in Russian mortality rates 1984–1994: artefact, alcohol, or what? Lancet. 1997;350:383–8.PubMedCrossRef
22.
go back to reference Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol. 2010;39:1279–90.PubMedCrossRef Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol. 2010;39:1279–90.PubMedCrossRef
23.
go back to reference Leon DA, Saburova L, Tomkins S, Andreev E, Kiryanov N, McKee M, et al. Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet. 2007;369:2001–9.PubMedCrossRef Leon DA, Saburova L, Tomkins S, Andreev E, Kiryanov N, McKee M, et al. Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet. 2007;369:2001–9.PubMedCrossRef
24.
go back to reference Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48, 557 adult deaths. Lancet. 2009;373:2201–14.PubMedCrossRef Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48, 557 adult deaths. Lancet. 2009;373:2201–14.PubMedCrossRef
25.
go back to reference McKee M, Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med. 1998;91:402–7.PubMed McKee M, Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med. 1998;91:402–7.PubMed
26.
go back to reference Leon DA, Shkolnikov VM, McKee M. Alcohol and Russian mortality: a continuing crisis. Addiction. 2009;104:1630–6.PubMedCrossRef Leon DA, Shkolnikov VM, McKee M. Alcohol and Russian mortality: a continuing crisis. Addiction. 2009;104:1630–6.PubMedCrossRef
27.
go back to reference Yarnell JW. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective epidemiological study of myocardial infarction. QJM. 1998;91:667–76.PubMedCrossRef Yarnell JW. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective epidemiological study of myocardial infarction. QJM. 1998;91:667–76.PubMedCrossRef
28.
go back to reference Tomkins S, Collier T, Oralov A, Saburova L, McKee M, Shkolnikov V, et al. Hazardous alcohol consumption is a major factor in male premature mortality in a typical Russian city: prospective cohort study 2003–2009. PLoS One. 2012;7:e30274.PubMedCrossRef Tomkins S, Collier T, Oralov A, Saburova L, McKee M, Shkolnikov V, et al. Hazardous alcohol consumption is a major factor in male premature mortality in a typical Russian city: prospective cohort study 2003–2009. PLoS One. 2012;7:e30274.PubMedCrossRef
29.
go back to reference Persijn JP, van der SW, Zwart WA. Colorimetric assay for -glutamyl transpeptidase. Clin Chim Acta. 1971;35:239–40.PubMedCrossRef Persijn JP, van der SW, Zwart WA. Colorimetric assay for -glutamyl transpeptidase. Clin Chim Acta. 1971;35:239–40.PubMedCrossRef
31.
go back to reference Schellenberg F, Wielders JP. Evaluation of capillary electrophoresis assay for CDT on SEBIA’s capillarys system: intra and inter laboratory precision, reference interval and cut-off. Clin Chim Acta. 2010;411:1888–93.PubMedCrossRef Schellenberg F, Wielders JP. Evaluation of capillary electrophoresis assay for CDT on SEBIA’s capillarys system: intra and inter laboratory precision, reference interval and cut-off. Clin Chim Acta. 2010;411:1888–93.PubMedCrossRef
32.
go back to reference Muthén B. Latent variable structural equation modeling with categorical data. J Econom. 1983;22:43–65.CrossRef Muthén B. Latent variable structural equation modeling with categorical data. J Econom. 1983;22:43–65.CrossRef
33.
go back to reference Muthén LK, Muthén BO. Mplus user’s guide. 4th ed. Los Angeles: Muthén & Muthén; 2006. Muthén LK, Muthén BO. Mplus user’s guide. 4th ed. Los Angeles: Muthén & Muthén; 2006.
34.
go back to reference StataCorp. Stata statistical software: release 11. College station, TX: StataCorp LP; 2009. StataCorp. Stata statistical software: release 11. College station, TX: StataCorp LP; 2009.
35.
go back to reference Chen L, Davey Smith G, Harbord RM, Lewis SJ. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med. 2008;5:e52.PubMedCrossRef Chen L, Davey Smith G, Harbord RM, Lewis SJ. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med. 2008;5:e52.PubMedCrossRef
36.
go back to reference Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. Br Med J. 2011;342:d636.CrossRef Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. Br Med J. 2011;342:d636.CrossRef
37.
go back to reference Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 1977;2:153–5.PubMedCrossRef Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 1977;2:153–5.PubMedCrossRef
38.
go back to reference Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the lipid research clinics follow-up study. Am J Epidemiol. 1987;126:629–37.PubMed Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the lipid research clinics follow-up study. Am J Epidemiol. 1987;126:629–37.PubMed
39.
go back to reference Muth ND, Laughlin GA, von Muhlen D, Smith SC, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo study. Br J Nutr. 2010;104:1034–42.PubMedCrossRef Muth ND, Laughlin GA, von Muhlen D, Smith SC, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo study. Br J Nutr. 2010;104:1034–42.PubMedCrossRef
40.
go back to reference Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012;307:2499–506.PubMedCrossRef Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012;307:2499–506.PubMedCrossRef
41.
go back to reference Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Br Med J. 2009;338:b92.CrossRef Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Br Med J. 2009;338:b92.CrossRef
42.
go back to reference Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012. doi:10.1016/S0140-6736(12)60312-2. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012. doi:10.​1016/​S0140-6736(12)60312-2.
43.
go back to reference Perova NV, Oganov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol. 1995;5:179–85.PubMedCrossRef Perova NV, Oganov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol. 1995;5:179–85.PubMedCrossRef
44.
go back to reference Averina M, Nilssen O, Brenn T, Brox J, Arkhipovsky VL, Kalinin AG. Factors behind the increase in cardiovascular mortality in Russia: apolipoprotein AI and B distribution in the Arkhangelsk study 2000. Clin Chem. 2004;50:346–54.PubMedCrossRef Averina M, Nilssen O, Brenn T, Brox J, Arkhipovsky VL, Kalinin AG. Factors behind the increase in cardiovascular mortality in Russia: apolipoprotein AI and B distribution in the Arkhangelsk study 2000. Clin Chem. 2004;50:346–54.PubMedCrossRef
45.
go back to reference Popova S, Rehm J, Patra J, Zatonski W. Comparing alcohol consumption in central and Eastern Europe to other European countries. Alcohol Alcohol. 2007;42:465–73.PubMedCrossRef Popova S, Rehm J, Patra J, Zatonski W. Comparing alcohol consumption in central and Eastern Europe to other European countries. Alcohol Alcohol. 2007;42:465–73.PubMedCrossRef
46.
go back to reference McKee M, Szucs S, Sarvary A, Adany R, Kiryanov N, Saburova L, et al. The composition of surrogate alcohols consumed in Russia. Alcohol Clin Exp Res. 2005;29:1884–8.PubMedCrossRef McKee M, Szucs S, Sarvary A, Adany R, Kiryanov N, Saburova L, et al. The composition of surrogate alcohols consumed in Russia. Alcohol Clin Exp Res. 2005;29:1884–8.PubMedCrossRef
47.
go back to reference Solodun YV, Monakhova YB, Kuballa T, Samokhvalov AV, Rehm J, Lachenmeier DW. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol. 2012;4:101–8. Solodun YV, Monakhova YB, Kuballa T, Samokhvalov AV, Rehm J, Lachenmeier DW. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol. 2012;4:101–8.
48.
go back to reference Gil A, Polikina O, Koroleva N, McKee M, Tomkins S, Leon DA. Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007. Alcohol Clin Exp Res. 2009;33:79–85.PubMedCrossRef Gil A, Polikina O, Koroleva N, McKee M, Tomkins S, Leon DA. Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007. Alcohol Clin Exp Res. 2009;33:79–85.PubMedCrossRef
49.
go back to reference Vikhert AM, Tsiplenkova VG, Cherpachenko NM. Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 1986;8:3A–11A.PubMedCrossRef Vikhert AM, Tsiplenkova VG, Cherpachenko NM. Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 1986;8:3A–11A.PubMedCrossRef
Metadata
Title
Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies
Authors
David A. Leon
Vladimir M. Shkolnikov
Svetlana Borinskaya
Juan-Pablo Casas
Alun Evans
Artyom Gil
Frank Kee
Nikolay Kiryanov
Martin McKee
Mark G. O’Doherty
George B. Ploubidis
Olga Polikina
Maxim Vassiliev
Stefan Blankenberg
Hugh Watkins
Publication date
01-05-2013
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 5/2013
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-013-9808-9

Other articles of this Issue 5/2013

European Journal of Epidemiology 5/2013 Go to the issue